Santhera Pharmaceuticals Holding has completed a 10:1 reverse split of its shares, which had been approved by the shareholders on June 27, 2023, with the listing and first day of trading of the post-split shares on the SIX
Tags :Eduard de Zordi
Homburger has provided legal counsel to Santhera Pharmaceuticals Holding (SIX: SANN “Santhera”) on its completion of a 10:1 reverse split of its shares. The reverse split, which was approved by shareholders on June 27, 2023, resulted in the
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
Meyer Burger Technology has successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The
Roche Finance Europe issued EUR 1.25 bn Bonds guaranteed by Roche Holding on February 27, 2023. The transaction consists of a EUR 750 m tranche due August 2029 and a EUR 500 m tranche due February 2035. Banco Santander, Barclays Bank and
Santhera Pharmaceuticals Holding announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management to provide up to CHF 22.2 million in aggregate, subject to certain milestones
Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
As we have informed last 8 November 2022 here, UBS has launched its CHF 375 million senior unsecured digital bond. UBS, acting through its London branch, successfully completed its inaugural issuance of digital bonds, consisting of CHF 375 m 2.330
Nestlé has issued CHF 930 million Bonds which will be listed on the SIX Swiss Exchange. The transaction consists of a CHF 360 million tranche due November 2025 (Tranche 1), a CHF 310 million tranche due November 2029 (Tranche 2) and a
Raiffeisen Schweiz Genossenschaft, a Swiss systemically relevant bank, successfully completed its issuance of EUR 500 million of 5.230 per cent. debt instruments for loss absorbency in the event of insolvency measures (bail-in bonds) due 2027 under its issuance
